Market cap
$-- Mln
Revenue (TTM)
$35 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-27 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
0
9 Years Aggregate
CFO
$-274.60 Mln
EBITDA
$-301.40 Mln
Net Profit
$-318.55 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Selecta Biosciences (SELB)
| 32.1 | 12.3 | 38.2 | 52.3 | -23.0 | -16.0 | -- |
|
BSE Sensex*
| -9.3 | 2.0 | 0.1 | -5.7 | 6.6 | 8.0 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Selecta Biosciences (SELB)
| 32.1 | -65.3 | 7.6 | 27.3 | -10.5 | -72.7 | -42.8 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Selecta Biosciences (SELB)
|
0.7 | -- | 34.5 | -40.3 | -169.5 | -59.7 | -- | 0.0 |
| 278.1 | 37,764.0 | 4,286.9 | 577.2 | 20.3 | 88.2 | 70.9 | 35.1 | |
| 81.8 | 10,481.2 | 622.0 | -300.9 | -25.7 | -61.1 | -- | 17.1 | |
| 51.9 | 13,354.5 | 2,375.5 | 833.4 | 41.5 | 40.7 | 17.6 | 6.9 | |
| 167.8 | 28,000.8 | 16,632.0 | 1,385.0 | 14.1 | 22.3 | 20.9 | 4.5 | |
| 505.8 | 11,084.5 | 1,132.5 | -309.4 | -25.0 | -52.9 | -- | 20.4 | |
| 460.2 | 13,347.1 | 2,678.3 | 460.4 | 21.3 | 103.2 | 29.4 | 22.3 | |
| 609.9 | 64,176.2 | 14,919.6 | 4,423.4 | 34.9 | 14.2 | 14.9 | 2.0 | |
| 536.6 | 23,174.2 | 3,169.8 | 1,287.4 | 51.3 | 20.6 | 20.2 | 3.9 | |
| 451.6 | 112,924.4 | 12,255.1 | 4,338.3 | 32.0 | 23.7 | 26.4 | 5.8 |
Shareholding Pattern
View DetailsAbout Selecta Biosciences (SELB)
--
-
CEO, Pres & Director
Dr. Carsten Brunn Ph.D.
-
VP of Fin. & Controller
Ms. Ann K. Donohue CPA
-
Headquarters
Watertown, MA
-
Website
FAQs for Selecta Biosciences (SELB)
What is the current share price of Selecta Biosciences Inc (SELB) Today?
The share price of Selecta Biosciences Inc (SELB) is $0.75 (NASDAQ) as of 26-Dec-2023 09:30 EDT. Selecta Biosciences Inc (SELB) has given a return of -23% in the last 3 years.
What is the current PB & PE ratio of Selecta Biosciences Inc (SELB)?
Since, TTM earnings of Selecta Biosciences Inc (SELB) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
What is the 52 Week High and Low of Selecta Biosciences Inc (SELB)?
The 52-week high and low of Selecta Biosciences Inc (SELB) are Rs -- and Rs -- as of 21-Jun-2026.
What is the market cap of Selecta Biosciences Inc (SELB)?
Selecta Biosciences Inc (SELB) has a market capitalisation of -- as on 26-Dec-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Selecta Biosciences Inc (SELB)?
Before investing in Selecta Biosciences Inc (SELB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.